Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: Bleomycin sulphate

References

• Anthony T, Fong P, Goyal A, Saltzman W, Moss R, Breuer C. Development of a parathyroid hormone-controlled release system as a potential surgical treatment for hypoparathyroidism. J Pediat Surg 2005; 40: 81–85
   PubMedGoogle Scholar
• Arnold M, Gorman E, Schieber L, Munson E, Berkland C. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Contr Rel 2007; 121: 100–109
   PubMed Web of Science ®Google Scholar
• Azouz S, Walpole J, Amirifeli S, Taylor K, Grinstaff M, Colson Y. Prevention of local tumor growth with paclitaxelloaded MSs. J Thorac Cardiovasc Surg 2008; 135: 1014–1021
   PubMed Web of Science ®Google Scholar
• Berkland C, King M, Cox A, Kim K, Pack D. Precise control of PLG MS size provides enhanced control of drug release rate. J Contr Rel 2002; 82: 137–147
   PubMed Web of Science ®Google Scholar
• Bodmeirer R, Alex R. Encapsulation of water soluble drugs by modified solvent evaporation method, I: Effect of process and formulation variables on the drug entrapment. J Microencapsulation 1990; 7: 347–355
   PubMedGoogle Scholar
• Chen S, Singh J. Controlled delivery of testosterone from smart polymer solution based systems: In vitro evaluation. Int J Pharm 2005; 295: 183–190
   PubMed Web of Science ®Google Scholar
• Chen S, Singh J. Controlled release of growth hormone from thermosensitive triblock copolymer systems: In vitro and in vivo evaluation. Int J Pharm 2008; 352: 58–65
   PubMed Web of Science ®Google Scholar
• Cui C, Stevens V, Schwendeman S. Injectable polymer MSs enhance immunogenicity of a contraceptive peptide vaccine. Vaccine 2007; 25: 500–509
   PubMedGoogle Scholar
• Deadman C, Kellaway I, Yasin M, Dickinson P, Murdan S. An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots. J Contr Rel 2007; 122: 79–85
   PubMed Web of Science ®Google Scholar
• Edlund U, Albertsson C. Degradable polymer MSs for controlled drug delivery. Adv Polym Sci 2002; 157: 67–112
   Web of Science ®Google Scholar
• Gasparini G, Kosvintsev S, Stillwell M, Holdich R. Preparation and characterization of PLGA particles for subcutaneouscontrolled drug release by membrane emulsification. Colloids Surf Biointerf 2008; 61: 199–207
   PubMed Web of Science ®Google Scholar
• George C, Tae P. Preparation of porous and nonporous biodegradable polymeric hollow MSs. J Contr Rel 1995; 35: 91–105
   Google Scholar
• Ghaderi R, Sturesson C, Carlfors J. Effect of preparative parameters on the characteristics of poly (D,L-lactide-co-glycolide) microspheres made by the double emulsion method. Intl J Pharm 1996; 141: 205–216
   Web of Science ®Google Scholar
• Hamdy S, Haddadi A, Somayaji V, Ruan D, Samuel J. Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (d,l-lacticco- glycolic acid) nanoparticle formulations. J Pharm Biomed Anal 2007; 44: 914–923
   PubMed Web of Science ®Google Scholar
• Hay T, Hou X, Lim J, Low A, Teo S, Tan H, Lee C. A novel drug-eluting stent using bioabsorbable polymer technology. Int J Cardiol 2009; 131: 272–274
   PubMedGoogle Scholar
• He W, Horn S, Hussain M. Improved bioavailability of orally administered mifepristone from PLGA nanoparticles. Int J Pharm 2007; 334: 173–178
   PubMed Web of Science ®Google Scholar
• Jalón E, Blanco-Pr´ıeto ZM, Ygartua P, Santoyo S. Topical application of acyclovir loaded microparticles: Quantification of the drug in porcine skin layers. J Contr Rel 2001; 75: 191–197
   PubMedGoogle Scholar
• Janusz W, Kostanski J, DeLuca P. A novel in vitro release technique for peptide containing biodegradable microspheres. AAPS Pharm Sci Tech 2000; 1(1)4
   Google Scholar
• Kasturi S, Qin H, Thomson K, El-Bereir S, Cha S, Neelapu S, Kwak L, Roy K. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. J Contr Rel 2006; 113: 261–270
   PubMedGoogle Scholar
• Kempen D, Lu L, Hefferan T, Creemers L, Maran A, Classic K, Dhert W, Yaszemski M. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008; 29: 3245–3252
   PubMed Web of Science ®Google Scholar
• Kim M, Ahn H, Shin Y, Cho M, Khang G, Lee H. An in vivo study of the host tissue response to subcutaneous implantation of PLGA and/or porcine small intestinal submucosa-based scaffolds. Biomaterials 2007; 28: 5137–5143
   PubMed Web of Science ®Google Scholar
• Krucoff M, Kereiakes J, Petersen J. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease. J Am Coll Cardiol 2008; 51: 1543–1552
   PubMed Web of Science ®Google Scholar
• Kunou N, Ogura Y, Hashizoe M, Honda Y, Hyon S, Ikada Y. Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits. J Contr Rel 1995; 37: 143–150
   Web of Science ®Google Scholar
• Li Y, Ogris M, Pelisek J. Stability and release characteristics of poly(d,l-lactide-co-glycolide) encapsulated CaPi-DNA coprecipitation. Int J Pharm 2004; 269: 61–70
   PubMed Web of Science ®Google Scholar
• Liman M, Peiser L, Zimmer G, Pr¨opsting M, Naim H, Rautenschlein S. A genetically engineered prime-boost vaccination strategy for oculonasal delivery with poly(d,l-lactic-co-glycolic acid) microparticles against infection of turkeys with avian Metapneumovirus. Vaccine 2007; 25: 7914–7926
   PubMed Web of Science ®Google Scholar
• Liu X, Heng W, Paul Li Q, Chan L. Novel polymeric MSs containing norcantharidin for chemoembiolization. J Contr Rel 2006; 116: 35–41
   PubMed Web of Science ®Google Scholar
• Mart´ınez-Sancho C, Herrero-Vanrell R, Negro S. Vitamin A palmitate and aciclovir biodegradable MSs for intraocular sustained release. Int J Pharm 2006; 326: 100–106
   PubMedGoogle Scholar
• Mata E, Carcaboso A, Herńandez R, Igartua M, Corradin G, Pedraz J. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falci- parum MSP2 long synthetic peptides in mice. Vaccine 2007; 25: 877–885
   PubMed Web of Science ®Google Scholar
• Miao X, Tan L, Tan L, Huang X. Porous calcium phosphate ceramics modified with PLGA–bioactive glass. Mater Sci Eng C 2007; 27: 274–279
   Web of Science ®Google Scholar
• Paiva M, Bublik M, Castro D, Udewitz M. Intratumor injections of cisplatin and laser thermal therapy for palliative treatment of recurrent cancer. Photomed Laser Surg 2005; 23(6)531–535
   PubMedGoogle Scholar
• Philip V, Mehta R, DeLuca P. In vitro and in vivo respirable isopropanol treated MS using dry powder inhaler. Int J Pharm 1997; 151: 175–182
   Web of Science ®Google Scholar
• Pistel KF, Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsulation 2000; 17: 467–483
   PubMed Web of Science ®Google Scholar
• Ranganath S, Wang C. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials 2008; 29: 2996–3003
   PubMed Web of Science ®Google Scholar
• Rawat A, Majumder Q, Ahsan F. Inhalable large porous MSs of low molecular weight heparin: In vitro and in vivo evaluation. J Contr Rel 2008; 128: 224–232
   PubMed Web of Science ®Google Scholar
• Ryu W, Huang Z, Prinz F, Goodman S, Fasching R. Biodegradable micro-osmotic pump for long-term and controlled release of basic fibroblast growth factor. J Contr Rel 2007; 124: 98–105
   PubMed Web of Science ®Google Scholar
• Sahoo S, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-coglycolide) nanoparticles affects their physical properties and cellular uptake. J Contr Rel 2002; 82: 105–114
   PubMed Web of Science ®Google Scholar
• Samstein R, Perica K, Balderrama F, Look M, Fahmy T. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials 2008; 29: 703–708
   PubMed Web of Science ®Google Scholar
• Sandor M, Harris J, Mathiowitz E. A novel polyethylene depot device for the study of PLGA and P(FASA) MSs in vitro and in vivo. Biomaterials 2002; 23: 4413–4423
   PubMed Web of Science ®Google Scholar
• Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006; 27: 4239–4249
   PubMed Web of Science ®Google Scholar
• Schwach G, Oudry N, Delhomme S, Lück M, Lindner H, Gurny R. Biodegradable microparticles for sustained release of a new GnRH antagonist part I: Screening commercial PLGA and formulation technologies. Eur J Pharm Biopharm 2003; 56: 327–336
   PubMed Web of Science ®Google Scholar
• Seo S, Choi H, Khang G, Rhee J, Lee H. A local delivery system for fentanyl based on biodegradablepoly(L-lactide-co-glycolide) oligomer. Int J Pharm 2002; 239: 93–101
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang J, Zhang X, Zhang Z, Zheng Y, Chen D, Zhang Q. Synchronic release of two hormonal contraceptives for about one month from the PLGA MSs: In vitro and in vivo studies. J Contr Rel 2008; 129: 192–199
   PubMed Web of Science ®Google Scholar
• Tang Y, Singh J. Controlled delivery of aspirin: Effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems. Int J Pharm 2008; 357: 119–125
   PubMedGoogle Scholar
• Teply B, Tong R, Jeong S, Luther G, Sherifi I, Yim C, Khademhosseini A, Farokhzad O, Langer R, Cheng J. The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules. Biomaterials 2008; 29: 1216–1223
   PubMed Web of Science ®Google Scholar
• Tian J, Sun X, Chen X, Yu J, Qu L, Wang L. The formulation and immunisation of oral poly(DL-lactide-co-glycolide)microcapsules containing a plasmid vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus). Int Immunopharmacol 2008; 8: 900–908
   PubMed Web of Science ®Google Scholar
• Wang F, He X, Jiang L, Ren D, He Y, Li D, Sun S. Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice. Vaccine 2006; 24: 2017–2026
   PubMedGoogle Scholar
• Wang J, Chua K, Wang C. Stabilization and encapsulation of human immunoglobulin G into biodegradable MSs. J Colloid Interf Sci 2004; 271: 92–101
   PubMed Web of Science ®Google Scholar
• Wen-I L, Anderson K, Mehta R, DeLuca P. Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA MSs prepared by solvent extraction/evaporation method. J Contr Rel 1995; 37: 199–214
   Google Scholar
• Zhou H, Zhang Y, Biggs D, Manning M, Randolph T, Christians U, Hybertson B, Ng K. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages. J Contr Rel 2005; 107: 288–299
   PubMed Web of Science ®Google Scholar
• Zhou T, Lewis H, Foster R, Schwendeman S. Development of a multiple drug delivery implant for intraocular management of proliferative vitreoretinopathy. J Contr Rel 1998; 55: 281–295
   PubMed Web of Science ®Google Scholar